Mimi's Rock

OUR INVESTORS

Become an integral part of Mimi's Rock and help supplement the health of people everywhere.

PRESS

See the latest in Mimi's Rock news.

TORONTOSept. 10, 2020

TORONTOSept. 10, 2020 – Mimi’s Rock Corp. (TSXV: MIMI) (the “Company”), an online dietary supplement and wellness company, today announced that all resolutions voted on at the annual and special meeting of shareholders of the Company held on September 8, 2020 were approved by shareholders. Shareholders voted in favour of the re-election of each of the incumbent directors, namely Telfer Hanson (Chair), Bryan Pearson (Lead Independent Director), David GrandinNorman BettsCharmaine Crooks and David Kohler.

In addition, the Company today announced the cancellation of an aggregate of 750,000 options (“Options”) to purchase common shares in the capital of the Company (“Common Shares”) and the issuance of Options to various employees, officers and directors to purchase up to a total of 920,000 Common Shares. The issued Options will expire 5 years from the date of grant and were issued on terms pursuant to TSX Venture Exchange policy and the Company’s stock option plan.

About Mimi’s Rock Corp.

Mimi’s Rock Corp. is an online dietary supplement and wellness company which market and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names. The Dr. Tobias brand features over 30 products, including the top-selling Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com. All Natural Advice and Maritime Naturals products focus on skin and beauty care. Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act. All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Forward-Looking Information

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

SOURCE Mimi’s Rock Corp.

Please visit www.mimisrock.com or www.sedar.com for the Company’s recent filings.

For further information, please contact:

David Kohler, CEO
905-330-5081
Dkohler@mimisrock.com

TORONTO, September 1, 2020

TORONTO, September 1, 2020 – Mimi’s Rock Corp. (TSXV:MIMI, OTCQB:MIMNF) (the “Company”), an online dietary supplement and wellness company, today announced the launch of a premium formula of hand sanitizer.

“We are keenly aware of the increasing global demand for hand sanitizer and the proliferation of inferior product in the market. Many products are hard on the skin, smell awful and leave an unpleasant residue. We have worked meticulously with our Canadian manufacturing partner, to create a hand sanitizer that we believe is one of the best on the market. With the successful launch in Canada under our All Natural Advice skin care brand, we intend to also distribute hand sanitizer in the US as soon as possible” said Dave Kohler, CEO. “We have initially launched an 8 oz size and will be coming to market in the near future with additional sizes and scents.”

New Dr Tobias Gummies

The Company also announced an extension to its lineup of vitamins.  The Dr Tobias brand will soon be entering the popular “vitamin gummies” space and will start with a strong line up of four products. All 4 products are expected to launch in the current quarter, in time for the busy Q4 selling season.

The new line will include:

    • Apple Cider Vinegar Gummy
    • Elderberry & Vitamin C Gummy
    • Joint Support Gummy
    • Hair Vitamin Gummy

Other recently completed launches by our Dr Tobias supplements brand:

    • Zinc 50mg
    • Elderberry Immune Support
    • Vitamin C 1000mg
    • Organics Green Complex
    • Magnesium Bisglycinay

We expanded our already strong Dr. Tobias immune defense portfolio to meet demands in the current global climate as it pertains to Covid-19.  The addition of these products are in direct response to the voice of our customers, who are looking for high quality offerings in these areas.

We continue to add distribution channels and products in countries around the world and will provide an update on these initiatives in early October.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

About Mimi’s Rock Corp.

Mimi’s Rock Corp. is an online dietary supplement and wellness company which market and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.  The Dr. Tobias brand features over 30 products, including the top-selling Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com.  All Natural Advice and Maritime Naturals products focus on skin and beauty care.  Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act.  All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Forward-Looking Information

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. The forward- looking statements in this press release include, but are not limited to, statements regarding the impact of the COVID-19 pandemic on the business and operations of the Company, the Company’s expected revenues, the expected increase in quarterly revenues and Adjusted EBITDA. Please refer to the Company’s 2019 Annual Financial Statements and MD&A for more details on the Company’s calculation of EBITDA and Adjusted EBITDA.

All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the forward-looking statements.

Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

Please visit www.mimisrock.com or www.sedar.com for the Company’s recent filings.

For further information, please contact:

David Kohler, CEO
905-330-5081
Dkohler@mimisrock.com

TORONTO, August 26, 2020

TORONTO, August 26, 2020 – Mimi’s Rock Corp. (TSXV:MIMI, OTCQB:MIMNF) (the “Company”), an online dietary supplement and wellness company, today announced its financial results for the three months ended June 30, 2020.

Highlights
  • $10.9 million revenue – Highest to date
  • $1.6 million EBITDA – Highest to date
  • $0.9 million after-tax net income

“The second quarter of 2020 financial results reflect the continued evolution of our business” said David Kohler, CEO. “Our positioning in the marketplace combined with our new product offerings, have resulted in our best results to date—and we are proud of what we have accomplished. We have seen that the COVID-19 virus has further accelerated consumer interest in shopping online. We are excited about the implications and expect growth to continue.”

Results of Operations for the Three Months Ended June 30, 2020

Net income for the second quarter of 2020 was $928,165 compared to a net loss of $1,240,051 in the same period in 2019. EBITDA for the second quarter of 2020 was $1,584,184, compared to EBITDA of $460,008 for the same period in 2019. Adjusted EBITDA (which excludes non-cash share-based compensation expenses, listing fees, foreign exchange gains (losses) and investment income) for the second quarter of 2020 was $1,573,165, ahead of the Adjusted EBITDA of $1,382,117 reported for the same period in 2019.

Revenues

Consolidated revenues for the second quarter of 2020 were $10,943,137, up 25% from revenues of $8,770,904 in the same period in 2019. Revenues were $10,943,137 for the three months ended June 30, 2020 compared to revenues of $8,770,904 for the period ended June 30, 2019. Revenues in the comparative 2019 period represent revenues from the DTI business only as the skin care businesses, All Natural and Maritime Naturals, were acquired in December 2019.

DTI, the core dietary supplements business, saw an improvement in its financial performance in the second quarter of 2020, indicating that it has completed its recovery from a difficult fourth quarter of 2019. Management expects the revenues of this business to experience some fluctuation on a quarter-to-quarter basis, but ultimately continue to grow throughout 2020 with the launch of new complementary products and expansion into additional geographic territories. Also, revenues from the skin care businesses are expected to continue to grow as the products enter the U.S. market.

Selling and Marketing Expense

The Company incurred selling and marketing expenses of $4,788,764, or approximately 43.8% of revenue, for the second quarter of 2020, compared to $3,523,242, or 40.2% of revenue, for the same period in 2019. In the 2019 period, management consciously scaled back online advertising to evaluate returns on investment. In Q2 2020, the level of online advertising was increased as management had become confident that its refined marketing strategy was gaining traction in the marketplace.

General and Administrative Expense

General and administrative expenses for the three months ended June 30, 2020 were $1,272,825, compared to $1,302,960 for the same period in 2019. General and administrative expenses consist primarily of salaries and benefits, professional fees, occupancy costs and insurance. General and administrative expenses are relatively comparable to the same period in 2019 due to the fact that staff and operational costs are relatively stable. General and administrative expenses are expected to remain relatively fixed for foreseeable future periods.

Interest Expense and Financing Costs

Interest and financing costs of $180,991 were incurred during the three months ended June 30, 2020, compared to $533,475 for the three months ended June 30, 2019. Interest and financing expenses have decreased significantly in 2020 periods compared to 2019 primarily due to renegotiations of the senior debt facility as well as lower interest rates and non-cash charges related to amortization of finance costs incurred in securing the loan.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. is an online dietary supplement and wellness company operating under the Dr. Tobias brand. The brand features over 30 products including the top selling colon cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. Mimi’s Rock currently serves customers in the United States and has rapid growth plans to expand into other markets. For more information, visit https://mimisrock.com.

Forward-Looking Information

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. The forward- looking statements in this press release include, but are not limited to, statements regarding the impact of the COVID-19 pandemic on the business and operations of the Company, the Company’s expected revenues, the expected increase in quarterly revenues and Adjusted EBITDA. Please refer to the Company’s 2019 Annual Financial Statements and MD&A for more details on the Company’s calculation of EBITDA and Adjusted EBITDA.

All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the forward-looking statements.

Forward-looking statements involve known and unknown risks, future events, conditions, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, prediction, projection, forecast, performance or achievements expressed or implied by the forward-looking statements, including risks relating to: the Company’s reliance on strength of reputation and brands, third-party manufacturing, transportation and distribution, the Company’s ability to protect its intellectual property, the Company’s reliance on e-commerce sites, disruption or breaches in information technology systems, the successful integration subsequent to acquisitions, litigation, volatility in the market price, the inability to successfully implement growth strategy on a timely basis, difficulty expanding sales in targeted international markets, changes in general economic conditions, the Company’s ability to service its debt obligations, management of growth, reliance on management, conflicts of interest, local and foreign tax matters, liquidity, currency and other financial risks, potential product liability or other regulatory claims, product recalls, the need to develop and innovate products, changes in legal and regulatory standards, competition, operating risk and insurance coverage, natural disasters, unusual weather and geo-political events, the effect of COVID-19 on operations and other risks relating to the business and industry of the Company that are detailed from time to time in the Company’s filings with the Canadian provincial securities regulators.

Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. All forward- looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

Please visit www.mimisrock.com or www.sedar.com for the Company’s recent filings.

For further information, please contact:

David Kohler, CEO
905-330-5081
Dkohler@mimisrock.com

TORONTOJune 30, 2020 /CNW/ – Mimi’s Rock Corp. (TSXV: MIMI) (the “Company”), an online dietary supplement and wellness company, today announced its financial results for the three months ended March 31, 2020.

Highlights

  • Q1 2020 Revenues of $10.4M – highest quarterly revenue to date
  • Q1 2020 Adjusted EBITDA of $1.23M


Recent Developments

  • On June 8, 2020, the Company announced several new products recently added to the Dr Tobias portfolio. Based on the demands of customers and in light of the focus on immunity support, the Company launched a number of new products focused on supporting the immune system. These products include Vitamin C, Elderberry Immune with Echinacea, Zinc and Vitamin C, as well as a 50mg Zinc product. The new additions complement the brands’ existing established portfolio of immune supporting products.

“Our first quarter 2020 results reflect the incredible efforts of our team, as we were able to re-establish the trajectory of the Dr Tobias brand’s growth ” said David Kohler, CEO.  “We identified and addressed a number of considerable challenges towards the end of 2019 and I’m pleased with the rapidity and efficiency with which we were able to course correct.  We have also been able to integrate the operations of the newly acquired skin care businesses and I am optimistic that the combination of these businesses with our core brands will allow us to drive even better performance over the balance of the year.”

Results of Operations for the Three Months Ended March 31, 2020

For the three months ended March 31, 2020, the Company earned net income of $281,515, compared to net income of $391,917 for the three months ended March 31, 2019.  EBITDA for the three months ended March 31, 2020 was $1,099,367, compared to $1,097,913 for the same period in 2019.  Adjusted EBITDA, which adds back (deducts) non-cash stock-based compensation, investment income, acquisition costs and listing expenses, was $1,228,070 for the three months ended March 31, 2020, compared to $1,318,520 for the same three month period in 2019.

Revenues and Gross Margin

Revenues were $10,435,311 for the three months ended March 31, 2020, compared to revenues of $10,166,227 for the three month period ended March 31, 2019.  Revenues reported in the current period primarily represent sales from the Company’s DTI GmbH (“DTI”) business as well as sales from All Natural and Maritime Naturals, acquired in December 2019.  Revenues in the comparative 2019 period primarily represent revenues from the DTI business only.  While the Company’s sales do not experience significant seasonality, there is some fluctuation on a quarterly basis due to natural demand fluctuation as well as promotional impacts.  In addition, the DTI business experienced significant changes in the market in mid- to late-2019 which put downward pressure on revenue with heavier advertising spend.  The first quarter of 2020 saw a return to previous sales and revenue levels, with sales increasing on a weekly basis throughout the quarter.  Revenues from the newly acquired skin care businesses, All Natural and Maritime Naturals, was in-line with expectations and historical performance.  The Company expects these revenues to continue to grow throughout 2020 as the businesses are integrated within the existing platform.

Revenues to date have been generated almost entirely through the Company’s online sales channels in the United StatesCanada and Europe.  Revenue growth in future quarters is expected to come from expansion into additional geographic territories as well as the launch of new complementary products.

Gross margin for the three months ended March 31, 2020 was $7,253,442 (69.5%) compared to $7,124,896 (70.1%) for the three month period ended March 31, 2019.  Costs of goods sold for the 2020 period includes an adjustment of $109,636 relating to recognition of fair value adjustments made on acquisition of All Natural and Maritime Naturals. Without consideration to this adjustment, gross margin for the period would have been 68.5%, an improvement over the 2019 period due to better pricing from suppliers as well as overall process efficiencies.

Selling and Marketing Expense

The Company incurred selling and marketing expenses of $4,748,087, or approximately 45.5% of revenue, for the three months ended March 31, 2020, compared to $4,502,744, or 44.3% of revenue, for the three months ended March 31, 2019.   The Company continues to adapt and further its brand strategy.  Online advertising in the period was increased with a focus on brand awareness and customer loyalty. Sales from its own e-commerce site, drtobias.com, as well through additional online retail outlets continued to grow; however, a majority of revenue continues to be generated on the Amazon platform.

Advertising spend in the first quarter of 2020 was lower than in recent periods but higher relative to sales than the first quarter of 2019.   Management spent considerable time and effort to understand challenges which presented in the DTI business in late 2019 and a recalibrated advertising strategy was able to provide support for an increase in sales volumes across most Dr Tobias products.   In addition, the Company was able to maintain sales growth such that current levels are comparable to those a year ago, despite operating challenges presented by COVID-19.   Short term promotions on new product launches will enable the business to continue to drive growth.  The Company continues to better understand its customer base, metrics and drivers in order to optimize advertising spend compared to revenue.

Selling and marketing expenses for the period consist primarily of fulfillment costs related to delivering products to customers, direct online advertising placements, costs related to marketing the Dr Tobias brand and other promotional and awareness initiatives.  The Company will continue to actively monitor its selling and marketing expenses, particularly direct advertising expenses and expects that these will begin to stabilize in relation to sales revenues going forward.

General and Administrative Expense

General and administrative expenses for the three months ended March 31, 2020 were $1,277,285, compared to $1,303,632 for the same period in 2019.  General and administrative expenses consist primarily of salaries and benefits, professional fees, occupancy costs and insurance.   General and administrative expenses are relatively comparable to the same period in 2019.  Staff and operational costs are relatively stable and expected to remain so going forward.

Share based Compensation Expense

Share based compensation expense relates to awards under the Company’s incentive stock option plan and is based on the estimated number of awards that will eventually vest using the Black-Scholes option pricing model.  Share based compensation expense for the three months ended March 31, 2020 was $71,182 compared to $212,372 for the three months ended March 31, 2019.  Share based compensation expense in 2019 was considerably higher due to initial vesting of employee grants.

Foreign Exchange Gains and Losses

Foreign exchange losses of $57,521 were recorded in the three months ended March 31, 2020, compared to $21,535 for the three months ended March 31, 2019, primarily due to the movements in the value of the US dollar relative to the Euro between the time that expenses were incurred and the time that they were settled.

Interest Expense and Financing Costs

Interest and financing costs of $244,738 were incurred during the three months ended March 31, 2020, compared to $467,471 for the three months ended March 31, 2019.  Interest and financing expenses have decreased significantly in the first quarter of 2020 compared to the same period in 2019 primarily due to renegotiations of the senior debt facility as well as lower interest rates and non-cash charges related to amortization of finance costs incurred in securing the loan.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. is an online dietary supplement and wellness company operating under the Dr. Tobias brand. The brand features over 30 products including the top selling colon cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. Mimi’s Rock currently serves customers in the United States and has rapid growth plans to expand into other markets. For more information, visit https://mimisrock.com.

Forward-Looking Information

This news release contains forward-looking statements and forward looking information within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. The forward looking statements in this press release include, but are not limited to, statements regarding the impact of the COVID-19 pandemic on the business and operations of the Company, the Company’s expected revenues, the expected increase in quarterly revenues and Adjusted EBITDA. Please refer to the Company’s 2019 Annual Financial Statements and MD&A for more details on the Company’s calculation of EBITDA and Adjusted EBITDA.

All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the forward-looking statements.

Forward-looking statements involve known and unknown risks, future events, conditions, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, prediction, projection, forecast, performance or achievements expressed or implied by the forward-looking statements, including risks relating to: the Company’s reliance on strength of reputation and brands, third-party manufacturing, transportation and distribution, the Company’s ability to protect its intellectual property, the Company’s reliance on e-commerce sites, disruption or breaches in information technology systems, the successful integration subsequent to acquisitions, litigation, volatility in the market price, the inability to successfully implement growth strategy on a timely basis, difficulty expanding sales in targeted international markets, changes in general economic conditions, the Company’s ability to service its debt obligations, management of growth, reliance on management, conflicts of interest, local and foreign tax matters, liquidity, currency and other financial risks, potential product liability or other regulatory claims, product recalls, the need to develop and innovate products, changes in legal and regulatory standards, competition, operating risk and insurance coverage, natural disasters, unusual weather and geo-political events, the effect of COVID-19 on operations and other risks relating to the business and industry of the Company that are detailed from time to time in the Company’s filings with the Canadian provincial securities regulators.

Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

Please visit www.mimisrock.com or www.sedar.com for the Company’s recent filings.

SOURCE Mimi’s Rock Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2020/30/c5134.html

David Kohler, CEO, 905-330-5081, Dkohler@mimisrock.comCopyright CNW Group 2020

TORONTOJune 17, 2020 /CNW/ – Mimi’s Rock Corp. (TSXV: MIMI) (OTCQB: MIMNF) (the “Company”) is pleased to announce the appointment of Charmaine Crooks, CM to the Board of Directors.

Charmaine Crooks is a five time Olympian, entrepreneur and community leader. Based in West Vancouver, Charmaine has over 20 years governance experience as a director on several national and international non-profit and public boards. As president and founder of NGU Consultants Inc (1997), Charmaine has provided strategic advisory and corporate development services to a variety of sectors including health, technology, sports and major events.

Recognized in 2018 as one of Canada’s Most Powerful Top 100 by the Women’s Executive Network (WXN), Charmaine is a respected contributor to the international business community.

“We are thrilled to welcome Charmaine Crooks to our team. Charmaine’s marketing, financial and governance skills will be welcomed at all levels of our organization. Her passion for success and commitment to excellence will be an asset in maintaining the high standards that we set for ourselves as an organization,” said Telfer Hanson, Executive Chairman of the Company.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. is an online dietary supplement and wellness company which market and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.  The Dr. Tobias brand features over 30 products, including the top-selling Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com.  All Natural Advice and Maritime Naturals products focus on skin and beauty care.  Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act.  All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Forward-Looking Information

This news release includes “forward-looking information,” as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Please visit www.mimisrock.com or www.sedar.com for recent Mimi’s Rock Corp. filings.

SOURCE Mimi’s Rock Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2020/17/c2320.html

Telfer Hanson, Executive Chairman, 416-230-3003, thanson@mimisrock.comCopyright CNW Group 2020

TORONTOJune 8, 2020 /CNW/ – Mimi’s Rock Corp. (TSXV: MIMI) (OTCQB: MIMNF) (the “Company”) today announced several new products recently added to its portfolio. The Dr Tobias brand has always been synonymous with the highest quality nutraceuticals. Based on the demands of our customers and in light of their newfound focus on immunity support, informed in part by the Covid-19 pandemic, the Company has recently launched a number of new products focused on supporting the immune system. The following is a list of new products that have been launched on Amazon.com:

NEW IMMUNE SUPPORTING PRODUCT LAUNCHES:

Vitamin C
Elderberry Immune – with Echinacea, Zinc and Vitamin C
Zinc 50mg

These new additions complement our existing established portfolio of immune supporting products:

Omega 3 Fish Oil (#1 on Amazon.com)
Adult Multivitamin
Deep Immune Probiotics & Prebiotics
Immune Daily
Prebiotics
Vitamin D3
Turmeric Curcumin
All-in-One Dog Chews

All the above products are available within the United States with several also available in Canada.

“Based on evolving consumer demand, our team has pivoted rapidly to develop and launch new immune support products. I couldn’t be prouder of our team, who’s professionalism has allowed for our company to benefit from changing consumer trends. Our business is well positioned to work from home and I am very pleased that the team has successfully executed our new launches from our new environment.” said David Kohler, CEO.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. is an online dietary supplement and wellness company which market and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.  The Dr. Tobias brand features over 30 products, including the top-selling Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com.  All Natural Advice and Maritime Naturals products focus on skin and beauty care.  Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act.  All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Forward-Looking Information

This news release contains forward-looking statements and forward looking information within the meaning of applicable securities laws.  All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the forward-looking statements.

Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

Please visit www.mimisrock.com or www.sedar.com for recent Mimi’s Rock Corp. filings.

SOURCE Mimi’s Rock Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2020/08/c1632.html

please contact Mimi’s Rock Corp. at: David Kohler, CEO, 905-330-5081, Dkohler@mimisrock.comCopyright CNW Group 2020

TORONTOJune 4, 2020 /CNW/ – Mimi’s Rock Corp. (TSXV: MIMI) (the “Company”), an online dietary supplement and wellness company, today announced its financial results for the year ended December 31, 2019.

Recent Developments

  • On February 24, 2020, the Company announced that its common shares were approved for trading on the OTCQB Venture Market (the “OTCQB”) under the ticker symbol MIMNF. The Company also received clearance from The Depositary Trust Company for transfer eligibility. The Company expects that the U.S. listing will increase the Company’s exposure and accessibility to the U.S. market, providing additional liquidity for shareholders, and raising the awareness of the Company’s brands to a much larger audience.

  • On April 7, 2020, the Company provided an operational update regarding COVID-19 and its impact on the business. While the proliferation of the coronavirus has forced the world to adapt, the Company has so far been able to navigate the consequential operational challenges. The Company has increased inventory levels on-hand with its e-commerce channel partners to help protect against the possibility of future supply chain disruptions. The Company has been able to maintain growth in its vitamins and supplements business. As well, the newly acquired skin care business has performed as expected, with no material decline in demand. At this time, management does not foresee any major disruptions to the Company’s business.

  • On April 22, 2020, the Company announced it would be relying on the 45-day extension period provided under the blanket relief from the Canadian Securities Administrators for the filing of its annual financial report for the year ended December 31, 2019 and the related management’s discussion & analysis (collectively, the “2019 Annual Financials”).

“The latter half of 2019 was challenging, as Amazon sellers met with significant changes within the platform. Frankly, we hit some “speed bumps” in Q3 and Q4, although I am pleased to announce that our team was responsive and effective in rapidly adapting and instituting a new approach. By Q1 2020, we began seeing the benefit of our operational adjustments. Further, the team’s impressive performance in integrating the All Natural Advice and Maritime Naturals lines, as well as reacting to the increased demands resulting from the COVID-19 pandemic, resulted in a strong Q1 and an improved financial outlook for 2020, of which we are very proud. We continue to launch new products and enter into new geographic jurisdictions each and every quarter, with improved efficiencies and operational performance. Our belief in the building of an online focused health products platform is well aligned with the current and future purchasing practices in the global marketplace. We see these recent events as driving even more consumers away from “bricks-and-mortar” retail and towards e-commerce, and we believe that our positioning and deeper understanding of the e-commerce world will allow us to continue to develop as a leader in in the new economy” said David Kohler, CEO.

Outlook for Q1 2020

The Company is establishing its initial outlook for fiscal 2020 and anticipates reported Q1 2020 results to be in the following range:

  • Expected Q1 2020 revenue of $10.3M – $10.6M
  • Expected Q1 2020 adjusted EBITDA of $1.2M – $1.4M

Results in this range would represent an increase in revenue of 33% to 37% over Q4 2019 and would represent the highest quarterly revenue level to date. While approximately half of this increase is from the newly acquired skin care businesses, the Dr Tobias brand also experienced a strong recovery in the first quarter of 2020. Management has implemented a new advertising strategy, streamlined processes and is focused on new market growth for the balance of 2020.

On May 29, 2020, the Company provided an update on the status of its 2019 Annual Financials and indicated that it would provide guidance on the timing to file its 2020 first quarter interim financial statements and related management’s discussion and analysis for the three months ended March 31, 2020 (collectively the “Q1 2020 Financials”) at the time of filing the 2019 Annual Financials. The Company continues to rely on the exemption under Ontario Instrument 51-502 – Temporary Exemption from Certain Corporate Finance Requirements, which instrument became effective as of March 23, 2020, in postponing the filing of its Q1 2020 Financials and expects to issue the Q1 Financials on or before June 30, 2020. Until such time as the Q1 Financials are filed, management and other insiders of the Company will be subject to an insider trading black-out consistent with the principles in section 9 of National Policy 11-207 Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions. The Company confirms that, except as disclosed by the Company, there have been no material business developments since May 29, 2020.

COVID-19

The Company is generally well positioned as a business to sustain through the disruption as a result of the pandemic as our products sales are all online. As we sell health and wellness products, the demand during the current outbreak has remained strong, particularly for certain immunity products. The initial outbreak and requests to self-isolate caused a brief but significant uptick in sales as consumers stocked-up on essentials. While the initial surge was not long-lasting, sales have continued to remain at levels at or above those seen prior to the outbreak.

Based on current information, we remain confident that we can continue to operate as the economy attempts to resume to normalcy. For precautionary reasons, over the past ten weeks we have taken the opportunity to increase our finished goods inventory on-hand from the normal 25 days to approximately 75 days on average. While this requires an additional investment in working capital, increased inventory in the fulfillment centres reduces the risk of delivery disruption. While the nature of the pandemic is such that it is difficult to predict how long it will last, there is so far no indication that the COVID-19 outbreak will have a negative impact on the Company’s business.

Results of Operations for the Year Ended December 31, 2019

For the year ended December 31, 2019, the Company incurred a net loss of $3,551,010 ($0.10 per share), compared to a net loss of $945,101 ($0.06 per share) for the year ended December 31, 2018. EBITDA for the year ended December 31, 2019 was $828,758, compared to $897,042 for the year ended 2018. adjusted EBITDA, which adds back (deducts) non-cash stock based compensation, investment income, acquisition costs and listing expenses, was $2,382,898 for the year ended December 31, 2019, compared to adjusted EBITDA of $2,736,093 for the year ended December 31, 2018.

Revenues and Gross Margin

Revenues were $35,409,072 for the year ended December 31, 2019 compared to revenues of $17,754,166 for the year ended December 31, 2018. Revenues reported in the current and prior year primarily represent revenues from the DTI business, which was acquired in July 13, 2018. While the Company’s sales do not experience significant seasonality, there is some fluctuation on a quarterly basis due to natural demand fluctuation as well as promotional impacts. Results of operations of the All Natural and Maritime Naturals businesses were included from the date of acquisition, however, had minimal impact due to their acquisition in mid-December 2019. The Company continues to adapt its brand strategy, advertising spend and execution strategies as conditions in the online dietary supplements market dictate. Beginning in Q2 2019, the Company began to see considerable shifts in the marketplace, however, advertising spend was adjusted and sales remained strong through the middle of the third quarter. Despite increasing advertising spend, sales continued to decline through Q4 2019.

Fourth quarter 2019 results reflected the full impact of the decline, as revenues were $7,716,827 for the three months ended December 31, 2019 compared to revenues of $9,231,216 for the three months ended December 31, 2018.

Management has made significant changes to its marketing strategy. While customer loyalty remained strong throughout 2019, new customer acquisition became increasingly difficult. The Dr Tobias brand began to see many new competitors emerge in mid-late 2019. As a result, costs to direct customer traffic began to get more expensive and less effective. Simultaneous with this market activity increase, changes in the way products were displayed on the Company’s primary marketplace had the impact of reducing the importance of rankings and reviews with a preference for paid advertisements. Despite increasing advertising spend and making investments in customer engagement, results did not show sufficient improvement such that management made a decision to terminate its relationship with its advertising partner. These changes seem to have made an impact in the period since year end.

As a result, sales and revenues have recovered in the period since December 31, 2019 to levels similar to those in Q2 2019 and prior. Sales from its own e-commerce site, drtobias.com, as well through additional online retail outlets continued to grow, however, a majority of sales of Dr Tobias products are generated through the Amazon.com sales channel in the United States.

Gross margin for the year ended December 31, 2019 was $24,759,327 (70%) compared to $11,963,253 (67%) for the year ended December 31, 2018. Since the acquisition of DTI, the Company has been able to improve efficiency and obtain better pricing from its supplier. Gross margin ratios have improved over the comparative period as a result.

Selling and Marketing Expense

The Company incurred selling and marketing expenses of $16,908,419, or 47.8% of revenue, for the year ended December 31, 2019, compared to $7,314,329, or approximately 41.2% of revenue, for the year ended December 31, 2018. Sales and marketing expenses for the period consist primarily of fulfillment costs related to delivering products to customers, direct online advertising placements, costs related to marketing the Dr. Tobias brand and other promotional and awareness initiatives. In the fourth quarter of 2019, the Company incurred selling and marketing expenses of $4,867,462, or 63.1% of revenue, compared to $4,013,384, or approximately 41.2% of revenue, for the fourth quarter of 2018. Advertising spend levels were considerably higher than originally anticipated due to strategies implemented to ensure protection of the brand and customer retention. Going forward, the Company expects selling and marketing expenses to return to more normal levels in the mid-40% range compared to revenue.

As the Company acquired the Dr Tobias brand in mid-2018, the first two quarters of 2019 involved understanding the dynamics of the Dr Tobias customer base as well as launching a new brand. Advertising spend in the third quarter of 2019 was increased with a deliberate focus on attracting longer term repeat customers. While the brand continues to generate strong repeat sales, investments are also being made attract new-to-brand customers. Despite consistent investment, returns in the form of revenue growth did not materialize. Organic growth began to decline until very late in 2019 as new strategies began to show results. The Company is confident it has appropriately adapted its advertising strategies in the near term as both efficiency and effectiveness of advertising has improved in the period since December 31, 2019. The Company will continue to actively monitor its selling and marketing expenses, particularly those directly related to advertising and expects that these will vary in relation to sales revenues going forward as advertising spend is optimized relative to competitive conditions.

General and Administrative Expense

General and administrative expenses for the year ended December 31, 2019 were $5,468,010, or 15.4% of revenue, compared to $1,912,831, for the year ended 2018, representing 10.8% of revenue. General and administrative expenses consist primarily of salaries and benefits, professional fees, occupancy costs and insurance. General and administrative expenses in the 2019 period are higher than the same period in 2018 primarily due to due a full year of operations of the Dr Tobias business as well as higher overall staff levels due to considerably more operational activity. General and administrative expenses were higher than considered typical in 2019, primarily due to certain one-time legal costs, as well as some employee relocation expenses.

Share based compensation expense relates to awards under the Company’s incentive stock option plan and is based on the estimated number of awards that will eventually vest using the Black-Scholes option pricing model. Share based compensation expense for the year ended December 31, 2019 was $617,461 compared to $549,744 for the year ended December 31, 2018.

Listing expenses of $786,138 in the year ended December 31, 2019 are related to the acquisition and reverse takeover transaction in connection with the Company’s public listing in May 2019 and are $nil for the same period in the prior year. Listing expenses include legal and professional fees, as well as $385,487 in non-cash charges related to the reverse takeover. Acquisition costs in the year ended December 31, 2019 were $99,788, incurred in connection with the acquisitions of All Natural and Maritime Naturals in December 2019. Acquisition costs of $1,267,590 were incurred in the year ended December 31, 2018 in connection with the acquisition of DTI.

Foreign exchange losses of $64,332 were recorded in the year ended December 31, 2019, compared to $48,379 for the year ended December 31, 2018, primarily due to the movements in the value of the US dollar relative to the Euro between the time that expenses were incurred and the time that they were settled.

Interest and financing costs of $2,735,815 were incurred during the year ended December 31, 2019, compared to $919,142 for the year ended December 31, 2018. Interest and financing expenses in the 2019 period include approximately $1,629,633 (2018: $354,755) in non-cash charges related to amortization of expenses incurred in securing the Company’s senior secured loan. Both the non-cash and total amount of expense was higher in 2019 due to the recognition of all unamortized costs incurred on the Company’s original senior secured debt upon refinancing in December 2019.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. is an online dietary supplement and wellness company operating under the Dr. Tobias brand. The brand features over 30 products including the top selling colon cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. Mimi’s Rock currently serves customers in the United States and has rapid growth plans to expand into other markets. For more information, visit https://mimisrock.com.

Forward-Looking Information

This news release contains forward-looking statements and forward looking information within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. The forward looking statements in this press release include, but are not limited to, statements regarding the impact of the COVID-19 pandemic on the business and operations of the Company, the anticipated timeline to file the Q1 2020 Financials, the Company’s expected revenues, the expected increase in quarterly revenues, and the expected adjusted EBITDA. Please refer to the 2019 Annual Financials for more details on the Company’s calculation of EBITDA and adjusted EBITDA.

All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the forward-looking statements.

Forward-looking statements involve known and unknown risks, future events, conditions, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, prediction, projection, forecast, performance or achievements expressed or implied by the forward-looking statements, including risks relating to: the Company’s reliance on strength of reputation and brands, third-party manufacturing, transportation and distribution, the Company’s ability to protect its intellectual property, the Company’s reliance on e-commerce sites, disruption or breaches in information technology systems, the successful integration subsequent to acquisitions, litigation, volatility in the market price, the inability to successfully implement growth strategy on a timely basis, difficulty expanding sales in targeted international markets, changes in general economic conditions, the Company’s ability to service its debt obligations, management of growth, reliance on management, conflicts of interest, local and foreign tax matters, liquidity, currency and other financial risks, potential product liability or other regulatory claims, product recalls, the need to develop and innovate products, changes in legal and regulatory standards, competition, operating risk and insurance coverage, natural disasters, unusual weather and geo-political events, the effect of COVID-19 on operations and other risks relating to the business and industry of the Company that are detailed from time to time in the Company’s filings with the Canadian provincial securities regulators.

Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

Please visit www.mimisrock.com or www.sedar.com for the Company’s recent filings.

SOURCE Mimi’s Rock Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2020/04/c8051.html

David Kohler, CEO, 905-330-5081, Dkohler@mimisrock.comCopyright CNW Group 2020

TORONTOMay 29, 2020 /CNW/ – Mimi’s Rock Corp. (TSXV:MIMI OTCQB:MIMNF) (the “Company”), an online dietary supplement and wellness company operating the Dr. Tobias, All Natural Advice and Maritime Naturals brands, announced today that it will release its 2019 financial results Thursday, June 4.

As announced on April 22, the Company expected its year end filings to be delayed due to issues surrounding COVID-19 and took relief provided by The Canadian Securities Administrators which provided for a blanket 45-day extension for periodic filings, including financial statements and management’s discussion and analysis.

Mimi’s Rock Corp. will file its annual financial report for the year ended December 31, 2019 and the related management’s discussion & analysis (collectively, the “2019 Disclosure Documents”) on June 4, 2020. At that time, the Company will provide guidance for its first quarter and expected timing for its Q1 2020 interim financial report for the three months ended March 31, 2020.

Until such time as the 2019 Disclosure Documents are filed, management and other insiders of the Company will be subject to an insider trading black-out consistent with the principles in section 9 of National Policy 11-207 Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions.

Since the date of release of the Company’s interim financial results for the three and nine months ended September 30, 2019, there have been no material business developments other than those disclosed in prior press releases.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. is an online dietary supplement and wellness company which market and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.  The Dr. Tobias brand features over 30 products, including the top-selling Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com.  All Natural Advice and Maritime Naturals products focus on skin and beauty care.  Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act.  All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Forward-Looking Information

This news release includes “forward-looking information,” as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Please visit www.mimisrock.com or www.sedar.com for recent Mimi’s Rock Corp. filings.

SOURCE Mimi’s Rock Corp.

Cision View original content: http://www.newswire.ca/en/releases/archive/May2020/29/c4261.html

David Kohler, CEO, 905-330-5081, Dkohler@mimisrock.comCopyright CNW Group 2020

TORONTOApril 22, 2020 /CNW/ -Mimi’s Rock Corp. (TSXV:MIMI OTCQB:MIMNF) (the “Company”), an online dietary supplement and wellness company operating the Dr. Tobias, All Natural Advice and Maritime Naturals brands, is providing an update on timing of the release of its audited financial results for the year ended December 31, 2019.

The Canadian Securities Administrators have recently announced temporary relief from certain regulatory filings required to be made on or before June 1, 2020 by reporting issuers in Canada, in view of the recent COVID-19 developments and the impact on market participants. The blanket relief provides a 45-day extension for periodic filings, including financial statements and management’s discussion and analysis.

Mimi’s Rock Corp. will be relying on the 45-day extension period provided under the blanket relief for the filing of its annual financial report for the year ended December 31, 2019 and the related management’s discussion & analysis (collectively, the “2019 Disclosure Documents”). The 2019 Disclosure Documents, which would otherwise have a filing deadline of April 29, 2020, are expected to be filed on SEDAR on or before May 29, 2020.   At this time, the Company is endeavouring to remain on schedule with Q1 2020 interim financial report for the three months ended March 31, 2020, currently due May 29, 2020, and will provide an update on timing once known.

Until such time as the 2019 Disclosure Documents are filed, management and other insiders of the Company will be subject to an insider trading black-out consistent with the principles in section 9 of National Policy 11-207 Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions.

Since the date of release of the Company’s interim financial results for the three and nine months ended September 30, 2019, there have been no material business developments other than those disclosed in prior press releases.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. is an online dietary supplement and wellness company which market and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.  The Dr. Tobias brand features over 30 products, including the top-selling Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com.  All Natural Advice and Maritime Naturals products focus on skin and beauty care.  Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act.  All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Forward-Looking Information

This news release includes “forward-looking information,” as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Please visit www.mimisrock.com or www.sedar.com for recent Mimi’s Rock Corp. filings.

SOURCE Mimi’s Rock Corp.

Cision View original content: http://www.newswire.ca/en/releases/archive/April2020/22/c5754.html

please contact Mimi’s Rock Corp. at: David Kohler, CEO, 905-330-5081, Dkohler@mimisrock.comCopyright CNW Group 2020

TORONTOApril 7, 2020 /CNW/ – Mimi’s Rock Corp. (TSXV:MIMI OTCQB:MIMNF) (the “Company”) today provided an operational update. Given the uncertain times, as we all grapple with the realities of the global pandemic, management thought it appropriate to provide a brief update on the Company’s operations and outlook. The Company is currently preparing its year-end financial statements and will announce the release date as soon as available. While the late part of 2019 was not as strong as management’s expectation, trends have begun to reverse in the first quarter of 2020.  While the proliferation of the COVID-19 virus has forced the world to adapt, we have so far been able to navigate the consequential operational challenges. As a result of operational changes implemented by our team (including the execution of multiple new on-line advertising strategies), combined with rapidly-evolving consumer behaviour driven at least in part by the COVID-19 pandemic, we have benefitted from continued sales growth in our vitamins and supplements business.  Meanwhile, the newly acquired skin care business remains strong.

Consumers are ordering more online and thinking about their overall wellness.  Our experienced supply chain management and operating teams have increased inventory levels on-hand with our e-commerce channel partners to deal with the increased product demand and to protect against any future supply chain disruptions.  We have not increased our prices as a result of the increased demand, and intend to hold our prices firm unless impacted with increased costs.

We are working diligently with our manufacturers and distributors to make sure that we continue meet the needs of our customers. Our team members are able to work from their homes, and there has been no impact on our day-to-day operational capabilities,” said Dave Kohler, CEO.

As a purely online business, Mimi’s Rock Corp.’s organizational structure has facilitated minimal disruption as employees perform duties remotely. At this time, management does not foresee any major disruptions to the Company’s business.  We will provide additional operational updates as appropriate, as we all work together to combat the current COVID-19 crisis.

About Mimi’s Rock Corp.

Mimi’s Rock Corp. is an online dietary supplement and wellness company which market and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.  The Dr. Tobias brand features over 30 products, including the top-selling Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com. All Natural Advice and Maritime Naturals products focus on skin and beauty care.  Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act.  All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Forward-Looking Information

This news release includes “forward-looking information,” as such this term is defined in applicable securities laws. Forward-looking information includes, without limitation, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results, and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward-looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control.  Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information.  All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Please visit www.mimisrock.com or www.sedar.com for recent Mimi’s Rock Corp. filings.

SOURCE Mimi’s Rock Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/April2020/07/c3387.html

please contact Mimi’s Rock Corp. at: David Kohler, CEO, 905-330-5081, Dkohler@mimisrock.comCopyright CNW Group 2020

TORONTOFeb. 21, 2020 /CNW/ – Mimi’s Rock Corp. (TSXV:MIMI) (the “Company”) is pleased to announce the Company have now shipped its third order in the 2020 year to Coupang. Coupang is South Korea’s largest online retailer. The top selling Dr. Tobias branded products are being sold on Coupang and the Company will launch its All Natural Advice branded products with Coupang shortly.

“Launching the South Korean marketplace started in late fall of 2019 and we are happy with both the speed of entry into this market, as well as the early performance of sales.” said Chirag Patel, Vice President of Operations and Corporate Strategy of Mimi’s Rock Corp.

About Mimi’s Rock Corp.

Mimi’s Rock Corp. is an online dietary supplement and wellness company which operates the Dr Tobias, All Natural Advice and Maritime Naturals brands. The Dr Tobias brand features over 30 products including the top-selling Colon 14 Day Cleanse and the #1 best-selling Omega 3 Fish Oil on Amazon.com. The Omega 3 Fish Oil is also the 4th largest subscribe & save product on Amazon.com. Mimi’s Rock Corp. has rapid growth plans as it continues to expand into global markets. For more information, visit www.mimisrock.com.

Forward-Looking Information

This news release includes “forward-looking information,” as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, the Company’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Please visit www.mimisrock.com or www.sedar.com for recent Mimi’s Rock Corp. filings.

SOURCE Mimi’s Rock Corp.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/February2020/21/c5160.html

Mimi’s Rock Corp., Telfer Hanson, Executive Chairman, 416-230-3003, Email: thanson@mimisrock.comCopyright CNW Group 2020

TORONTOJan. 23, 2020 /CNW/ – Mimi’s Rock Corp. (TSXV:MIMI) and Avivagen Inc. (TSXV:VIV) (collectively “the Companies”) are pleased to announce the Dr Tobias Dog Chews containing the proprietary Avivagen OxC-BetaTM additive are now available in the United States on Amazon and Drtobias.com.

“We’ve been working closely with the Avivagen team to launch the first Dr Tobias branded product into the companion pet market in the United States. With an ever-expanding companion pet market, we believe that our existing Dr Tobias customers will embrace the opportunity to provide the same high standards in supplements and vitamins to their dogs,” said Dave Kohler, CEO of Mimi’s Rock Corp.

“We’re very excited to bring our high quality supplement for companion animals to this important and growing $10 billion per year market,” says Kym Anthony, Chief Executive Officer, Avivagen Inc. “We believe the combination of Avivagen’s OxC-betaTM technology with Mimi’s Rock’s expertise in online sales and customer service is a win-win scenario for both enterprises, and look forward to building upon this partnership.”

About Mimi’s Rock Corp.

Mimi’s Rock Corp. is an online dietary supplement and wellness company which operates the Dr Tobias, All Natural Advice and Maritime Naturals brands. The Dr Tobias brand features over 30 products including the top-selling Colon 14 Day Cleanse and the #1 best-selling Omega 3 Fish Oil on Amazon.com. The Omega 3 Fish Oil is also the 4th largest subscribe & save product on Amazon.com. Mimi’s Rock Corp. has rapid growth plans as it continues to expand into global markets. For more information, visit www.mimisrock.com.

About Avivagen Inc.

Avivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance. It’s a public corporation traded on the TSX Venture Exchange under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada and Charlottetown, Prince Edward Island. For more information, visit www.avivagen.com. The contents of the website are expressly not incorporated by reference in this press release.

Forward-Looking Information

This news release includes “forward-looking information,” as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, discussion of Bloom Burton and its conference, The Companies business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Companies caution that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Companies control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Companies judgement as of the date of this new release, and the Companies are under no obligation to update or alter any forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Please visit www.mimisrock.com or www.sedar.com for recent Mimi’s Rock Corp. filings.  Please visit www.avivagen.com or www.sedar.com for recent Avivagen Inc. filings.

Copyright © 2020 Avivagen Inc. OxC-beta™ is a trademark of Avivagen Inc.

SOURCE Mimi’s Rock Corp.

View original content: http://www.newswire.ca/en/releases/archive/January2020/23/c0383.html

Mimi’s Rock Corp., Telfer Hanson, Executive Chairman, 416-230-3003, Email: thanson@mimisrock.com; Avivagen Inc., Drew Basek, Director of Investor Relations, 100 Sussex Drive, Ottawa, Ontario, Canada K1A 0R6 Phone: 416-540-0733, E-mail: d.basek@avivagen.com; Kym Anthony, Chief Executive Officer, 100 Sussex Drive, Ottawa, Ontario, Canada K1A 0R6 Head Office Phone: 613-949-8164, Website: www.avivagen.comCopyright CNW Group 2020

TORONTO, January 8, 2020

Source: Mimi’s Rock Corp.

TORONTO, January 8, 2020 – Mimi’s Rock Corp. (‘Mimi’s Rock’ or the ‘Company’) (TSXV:MIMI) an online dietary supplement and wellness company operating the Dr. Tobias, All Natural Advice and Maritime Naturals brands, is pleased to announce the Company has entered into an exclusive agreement with WestGoods Inc. (the “Buyer”) for the sale of our brands in The People’s Republic of China.

The Supply Agreement with the Buyer is for a term of five years and includes minimum sales requirements for the Buyer to maintain the license. WestGoods Inc. has been successfully distributing the recently-acquired All Natural Advice products for the past six months and will now expand distribution with the sale of our Dr. Tobias and Maritime Naturals lines.

‘We have promised our shareholders consistent expansion of distribution channels and we continue to meet that commitment. When we acquired the Dr. Tobias brand eighteen months ago, our sales were to the US market only. Our product lines are now sold in the US, Canada, Germany the UK, Italy, Australia and China’ said Dave Kohler, CEO of Mimi’s Rock.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

About Mimi’s Rock Corp.

Mimi’s Rock Corp. is an online dietary supplement and wellness company which operates the Dr. Tobias, All Natural Advice and Maritime Naturals brands. The brand features over 30 products including the top selling colon cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. The Omega 3 Fish Oil is also the 4th largest subscribe & save product on Amazon.com. Mimi’s Rock has rapid growth plans to continue to expand into global markets. For more information, visit Mimisrock.com.

Forward-Looking Information.

This news release includes ‘forward-looking information,’ as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, discussion of Bloom Burton and its conference, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO

905-330-5081

dkohler@mimisrock.com

Telfer Hanson, Executive Chairman

416-230-3003

thanson@mimisrock.com

TORONTO, December 16, 2019

Source: Mimi’s Rock Corp.

(Toronto: December 16, 2019) Mimi’s Rock Corp. (‘Mimi’s Rock’ or the ‘Company’) (TSXV:MIMI), is pleased to announce a new line of nutritional supplements, launched under the brand ‘LENNOX by Dr Tobias’, is now available in the United States on Amazon.com, and on drtobias.com

Lennox Lewis is a former professional boxer who competed from 1989 to 2003. He is a three-time world heavyweight champion, a two-time lineal champion, and remains the last heavyweight to hold the undisputed title. Holding dual British and Canadian citizenship, Lewis represented Canada as an amateur in the 1988 Summer Olympics, winning a gold medal in the super-heavyweight division.

‘We have been working with Lennox to formulate three unique daily multipack supplements for Performance, Daily Essentials and Joint Support. These multi-packs make it convenient to ensure athletes – and former athletes – are getting a great daily supplement mix, which supports their needs. Lennox has a deep personal interest in not just maintaining health, but pushing for improvements as he ages. The Lennox and Mimi’s Rock teams are dedicated to creating products that will allow others to do the same’ said Dave Kohler, CEO of Mimi’s Rock.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

About Mimi’s Rock Corp.

Mimi’s Rock Corp. is an online dietary supplement and wellness company which operates the Dr. Tobias brand. The brand features over 30 products including the top selling colon cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. The Omega 3 Fish Oil is also the 4th largest subscribe & save product on Amazon.com. Mimi’s Rock currently serves customers in the United States and Canada, and has rapid growth plans to expand into other markets. For more information, visit https://mimisrock.com.

Forward-Looking Information

This news release includes ‘forward-looking information,’ as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, discussion of Bloom Burton and its conference, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO

905-330-5081

dkohler@mimisrock.com

Telfer Hanson, Executive Chairman

416-230-3003

thanson@mimisrock.com

TORONTO, December 13, 2019

Source: Mimi’s Rock Corp.

(Toronto: December 13, 2019) Mimi’s Rock Corp. (‘Mimi’s Rock’ or the ‘Company’) (TSXV:MIMI) is pleased to announce the successful completion of its previously-announced acquisition of All Natural Advice Ltd. (‘All Natural’) and Maritime Naturals Ltd. (‘Maritime Naturals’) by way of a share purchase transaction. Combined, the acquired businesses generated approximately $5.5 million of revenue and $1.6 million of EBITDA over the past twelve months, with consolidated revenue growing 29% year over year and EBITDA growth of 109% on a year over year basis. In connection with the transaction, the Company has renegotiated its senior credit facility, providing cash for the acquisition while reducing borrowing costs.

‘This acquisition is not only immediately accretive, it is also an excellent strategic fit for Mimi’s Rock Corp. All Natural Advice has business in several European countries which were future target markets for us. This allows us to accelerate our strategy’ said Dave Kohler, CEO of Mimi’s Rock.

The purchase price was satisfied by (i) payment, in aggregate, of approximately $5.5 million in cash, (ii) the issuance of an aggregate of 3,203,048 common shares in the capital of Mimi’s Rock, 75% of which will remain still subject to escrow, and (iii) the assumption of a loan from the vendors in the amount of approximately $2 million, which loan is to be repaid within 12 months of closing. The cash portion of the purchase price is paid with a combination of cash on hand and additional borrowings under the Company’s long-term debt facility with the Bank of Nova Scotia, the terms of which was amended and restated on December 13, 2019.

All Natural and Maritime Naturals currently offer products in Germany, Italy, UK and Australia, giving Mimi’s Rock immediate access to these markets. The Company believes that their products will allow Mimi’s Rock to offer 45 additional SKUs to its already impressive basket of products by offering anti-ageing organic skincare products, all-natural masks & scrubs, acne blemish treatments, beard oils and more.

Senior Debt Refinancing.

On December 13, 2019, the Company modified its secured debt facility, as originally entered into on July 6, 2018. The revised facility matures on December 13, 2022 and provides for a $16,632,000 term loan repayable over four years, initially at the Canadian Bankers’ Acceptance (“BA”) rate plus 3.0%, or approximately 4.95% effective rate, with quarterly payments of principal and interest beginning March 2020. The revised credit facility also continues to provide for an operating line of credit, secured by inventory and accounts receivable, as well as corporate credit cards. Importantly, the requirement that the Company insure its debt with Export Development Canada has been removed, lowering the Company’s overall cost of capital.

The facility is secured by all assets of the Company and contains affirmative and negative covenants including compliance with laws and restrictions on additional debt, as well as traditional financial covenants such as debt to earnings and other coverage ratios. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

About Natural Advice and Maritime Naturals.

All Natural Advice and Maritime Naturals, based in Ontario and Nova Scotia, respectively, are companies focused on skin and beauty care. Products sold by All Natural and Maritime Naturals are made in Canada and registered under Health Canada and under the EU Cosmetics Act. Together, All Natural and Maritime Naturals have over 45 products in jurisdictions around the world. All Natural has been featured on BNN as a top selling skincare brand in Canada and has been rated the #1 Beauty Brand on Amazon Canada for the past 4 years.

About Mimi’s Rock Corp.

Mimi’s Rock Corp. is an online dietary supplement and wellness company operating under the Dr. Tobias brand. The brand features over 30 products including the top selling colon cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. The Company currently serves customers in the United States and has rapid growth plans to expand into other markets.

Forward Looking Statements

This news release may contain forward-looking statements or ‘forward-looking information’ within the meaning of applicable Canadian securities laws (‘forward-looking statements’). Often, but not always, forward-looking statements can be identified by the use of words such as ‘plans’, ‘expects’ or ‘does not expect’, ‘is expected’, ‘budget’, ‘scheduled’, ‘estimates’, ‘forecasts’, ‘intends’, ‘anticipates’ or ‘does not anticipate’, or ‘believes’, or describes a ‘goal’, or variation of such words and phrases or state that certain actions, events or results ‘may’, ‘could’, ‘would’, ‘might’ or ‘will’ be taken, occur or be achieved.

All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements. Forward-looking statements involve known and unknown risks, future events, conditions, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, prediction, projection, forecast, performance or achievements expressed or implied by the forward-looking statements. Such factors include, among others, internal and external factors disclosed in the most recent annual information form of the Company and other documents publicly filed by the Company. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the ‘U.S. Securities Act’) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.

For more information, please visit Mimisrock.com

For further information, please contact:

Telfer Hanson

416 230 3003

info@mimisrock.com

TORONTO, November 28, 2019

Source: Mimi’s Rock Corp.

TORONTO, November 28, 2019 – Mimi’s Rock Corp. (TSXV:MIMI) “The Company”, an online dietary supplement and wellness company operating the Dr. Tobias brand, today announced its financial results for the quarter ended September 30, 2019.

Recent Developments

  • On September 5, 2019, the Company announced it had entered into binding agreements to acquire two additional businesses. Agreements to acquire All Natural Advice Ltd. (‘All Natural’) and Maritime Naturals Ltd. (‘Maritime Naturals’) are expected to be completed shortly. All Natural is the #1 Skin Care Seller on Amazon Canada for the past 4 years. Mimi’s Rock will acquire all of the issued and outstanding shares of each of All Natural and Maritime Naturals for an aggregate purchase price of approximately $9.6 million. The acquisition of these accretive businesses will add approximately $5.5 million of combined revenue and $1.6 million of EBITDA. Closing for both acquisitions is scheduled for December 10, 2019.
  • On September 24, 2019, the Company announced (further to the joint venture announcement of July 8, 2019) the execution of a definitive agreement with three-time world heavyweight champion Lennox Lewis to develop and commercialize a new line of branded nutritional supplements. The co-branded supplements will focus on men’s health and wellness and will feature products such as a Men’s Multipack Vitamin. Products will be sold exclusively online.
  • On November 13, 2019, the Company announced the launch of its Dr. Tobias line of dietary supplements in Canada. Initially, Dr Tobias will be launching the brand’s top-rated Omega 3 Fish Oil, known to support cardiovascular health, cognitive health and brain function, and its Multivitamin, a product which promotes eye, skin, membrane, and immune function and fosters strong bones and teeth. These product launches have been made available on Amazon.ca and on the e-commerce platform drtobias.com.
  • On November 27, 2019, the Company announced that the TSX Venture Exchange has accepted the Company’s notice to implement a normal course issuer bid (‘NCIB’) to purchase, for cancellation, up to 3,029,109 of its common shares, representing approximately 10% of the Company’s ‘public float’. Management of the Company believes that the Shares have been trading in a price range which does not adequately reflect their value and that the purchase of the Shares under the NCIB is in the best interests of the Company, a desirable use of its available cash, and will enhance shareholder value in general.

Dave Kohler, CEO of Mimi’s Rock commented, ‘We are excited to be launching multiple new products and categories in new markets. These, coupled with the pending acquisition of All Natural and Maritime Naturals, give us access to new revenue streams and offer diversification from the single-market roots of the organization. As we continue to execute our strategies, these markets should contribute significantly to our growth’.

Results of Operations.

For the three months ended September 30, 2019, the Company incurred a net loss of $243,156 compared to a net loss of $759,537 for the three months ended September 30, 2018. For the three months ended September 30, 2019, EBITDA was $626,540, compared to EBITDA of $216,887 for the three months ended September 30, 2018. Adjusted EBITDA, which excludes non-cash share based compensation expense, investment income, listing expenses and acquisition costs, was $902,776, compared to Adjusted EBITDA of $1,530,973 for the same period in the prior year. For the nine months ended September 30, 2019, the Company incurred a net loss of $1,091,290 ($0.03 per share), compared to a net loss of $759,537 ($0.05 per share) for the nine month period ended September 30, 2018. EBITDA for the nine months ended September 30, 2019 was $2,184,461, compared to $216,887 EBITDA for the same period in the prior year. Adjusted EBITDA was $3,603,413 for the nine months ended September 30, 2019, compared to $1,530,973 for the same period in 2018.

The Company reported a net loss for the three and nine months ended September 30, 2019 primarily due to one- time costs related to its reverse takeover and public listing expenses as part of the Qualifying Transaction completed in May 2019, as well as non-cash share-based compensation expense. Tax expense in the nine month period was also higher than normal due to derecognition of tax loss carryforwards in Germany as a result of the reverse acquisition.

Revenues for the three months ended September 30, 2019 were $8,755,114 compared to revenues of $8,522,950 for the three month period ended September 30, 2018. Revenues represent sales of nutraceutical products in the U.S. market. Gross margin for the three months ended September 30, 2019 was $6,114,962 (70%) compared to $5,553,930 (65%) for the three month period ended September 30, 2018. Gross margin ratios have improved over the comparative period as the Company works with its supplier to obtain better pricing and efficiencies. Revenues were $27,692,245 for the nine months ended September 30, 2019 compared to revenues of $8,522,950 for the nine months ended September 30, 2018. Revenues reported in the current and prior year primarily represent revenues from the DTI business, which began to accrue to the Company from July 13, 2018, the date of acquisition. Revenues from the core business have remained strong with some seasonality. The Company has begun to add additional sales channels through the launch of its own e-commerce site and sales to other e- commerce outlets. Going forward, growth is expected to come from launch of product sales in additional geographic regions as well as other online portals.

The Company continues to adapt and further its brand strategy. Online advertising in the period was increased with a focus on brand awareness and customer loyalty. Sales from its own e-commerce site, drtobias.com, as well through additional online retail outlets continued to grow, however, a majority of revenue continues to be generated on the Amazon.com platform.

The Company incurred selling and marketing expenses of $4,014,971, or approximately 46% of revenue, for the three months ended September 30, 2019, compared to $3,300,945, or 39% of revenue, for the three months ended September 30, 2018. Advertising spend in the third quarter of 2019 was increased with a deliberate focus on attracting longer term repeat customers. While the brand continues to generate strong repeat sales, investments are also being made attract new-to-brand customers. While this type of ad spend does not necessarily translate to immediate revenue, it is important to the overall brand growth strategy. Sales and marketing expenses for the period consist primarily of fulfillment costs related to delivering products to customers, direct online advertising placements, costs related to marketing the Dr. Tobias brand and other promotional and awareness initiatives. The Company will continue to actively monitor its selling and marketing expenses, particularly those directly related to advertising and expects that these will vary in relation to sales revenues going forward as advertising spend is optimized relative to competitive conditions.

General and administrative expenses for the three months ended September 30, 2019 were $1,197,215, compared to $722,012 for the same period in 2018. General and administrative expenses consist primarily of salaries and benefits, professional fees, occupancy costs and insurance. General and administrative expenses in the 2019 period are higher than the same period in 2018 primarily due to higher overall staff levels and considerably more operational activity. Share based compensation expense for the three months ended September 30, 2019 was $123,747 compared to $326,685 for the three months ended September 30, 2018. Share based compensation expense in 2018 was considerably higher due to initial vesting of original employee grants. Share based compensation expense relates to awards under the Company’s incentive stock option plan and is based on the estimated number of awards that will eventually vest using the Black-Scholes option pricing model.

On May 27, 2019, the Company completed its Qualifying Transaction pursuant to an amalgamation agreement between the Company and Mimi’s Rock Inc. The Qualifying Transaction constituted a reverse take-over (‘RTO’) for accounting purposes, as former MRI shareholders hold a majority of outstanding shares in the Company, the Board of Directors is comprised of MRI Board members and the senior management of MRI became senior management of the Company. Listing expenses related to the acquisition and reverse takeover transaction were $786,138, compared to $nil for the same period in the prior year. Listing expenses consistprimarily of legal, accounting and other professional fees associated with the reverse takeover and amalgamation, as well as non-cash costs related to equity instruments issued for the acquisition.

Interest and financing costs of $426,409 were incurred during the three months ended September 30, 2019, compared to $447,076 for the three months ended September 30, 2018. Interest and financing expenses in the 2019 period include approximately $183,543 (2018: $137,106) in non-cash charges related to amortization of expenses incurred in securing the Company’s senior secured loan.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. is an online dietary supplement and wellness company operating under the Dr. Tobias brand. The brand features over 30 products including the top selling colon cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. Mimi’s Rock currently serves customers in the United States and has rapid growth plans to expand into other markets. For more information, visit Mimisrock.com.

Forward-Looking Information

This news release includes “forward-looking information,” as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO

905-350-5081

DKohler@mimisrock.com

TORONTO, November 13, 2019

Source: Canada Newswire

Mimi’s Rock Corp. (‘MR’ or ‘the Company’) (TSXV: MIMI), an online dietary supplement and wellness business, is pleased to announce the launch of its Dr. Tobias line of dietary supplements in Canada.

The first of the Dr. Tobias supplements are now available both via the drtobias.com e-commerce platform and on Amazon.ca. These will be followed by a cadence of additional products in the weeks and months ahead. Initially, Dr Tobias will be launching the brand’s top-rated Omega 3 Fish Oil, known to support cardiovascular health, cognitive health and brain function, and its Multivitamin, a product which promotes eye, skin, membrane, and immune function and fosters strong bones and teeth.

‘We are thrilled to be launching our Dr. Tobias brand in Canada. This marks our first new international market entrance for our business, beyond our primary marketplace (the USA) and is an important step in the execution of our planned multinational expansion. This product launch in Canada further demonstrates our team’s ability to execute on our strategies and to bring our diversified products and brands to a virtually unlimited global market,’ said David Kohler, CEO of Mimi’s Rock Corp.

These product launches have been made available on Amazon.ca and on the e-commerce platform drtobias.com.

About Mimi’s Rock Corp.:.

Mimi’s Rock Corp. is an online dietary supplement and wellness company under which the Dr. Tobias brand is operated. The brand features more than 30 products, including the top-selling Colon Cleanse and the number-one selling Omega 3 Fish Oil, which is also the 4th largest Subscribe and Save product on Amazon.com. Mimi’s Rock now serves customers in the United States through Amazon.com, Walmart.com, and Dr. Tobias.com, and in Canada through Amazon.ca and Drtobias.com, with a plan for rapid growth and expansion into other markets. For more information, visit https://mimisrock.com.

Forward-Looking Information

This news release includes ‘forward-looking information,’ as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, discussion of Bloom Burton and its conference, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

View original content: Newswire.ca/News-Release

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO

905-350-5081

DKohler@mimisrock.com

TORONTO, September 24, 2019

Source: Canada Newswire

Mimi’s Rock Corp. (TSXV:MIMI) ‘The Company’, an online dietary supplement and wellness company operating the Dr. Tobias brand, is pleased to announce, further to the joint venture announcement of July 8, 2019, the execution of a definitive agreement with three-time world heavyweight champion Lennox Lewis to develop and commercialize a new line of branded nutritional supplements.

The co-branded supplements will focus on men’s health and wellness, and will feature products such as a Men’s Multipack Vitamin. Products will be sold exclusively online.

Lennox will provide social media and marketing support in respect of the products, which will bear his name and likeness, and be co-branded with Dr. Tobias, leveraging the strength of the Dr. Tobias products with Lennox Lewis’ reputation and celebrity as well as his significant following.

About Lennox Lewis:

Lennox Lewis, CM, CBE, nicknamed ‘The Lion’, is a retired professional boxer who remains the last heavyweight to hold the undisputed title. He competed from 1989 to 2003, and is a three-time world heavyweight champion and two-time Lineal champion. Holding dual British and Canadian citizenship, Lewis represented Canada as an amateur in the 1988 Summer Olympics, winning a gold medal in the super-heavyweight division.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. is an online dietary supplement and wellness company operating under the Dr. Tobias brand. The brand features over 30 products including the top selling Colon Cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. The Omega 3 Fish Oil is also the 4th largest subscribe & save product on Amazon.com. Mimi’s Rock currently serves customers in the United States through Amazon.com, Walmart.com, and Dr. Tobias.com, with a rapid growth plan to expand into other markets. For more information, visit Mimisrock.com.

Forward-Looking Information

This news release includes ‘forward-looking information,’ as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, discussion of Bloom Burton and its conference, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

View original content: Newswire.ca/News-Release

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO

905-350-5081

DKohler@mimisrock.com

TORONTO, September 5, 2019

Source: Canada NewsWire

TORONTO, Sept. 5, 2019 /CNW/ – Mimi’s Rock Corp. (‘Mimi’s Rock’ or ‘the Company’) (TSXV: MIMI), an online dietary supplement and wellness business, is pleased to announce it has entered into binding agreements to acquire two additional businesses, namely All Natural Advice Ltd. (‘All Natural’) and Maritime Naturals Ltd. (‘Maritime Naturals’). All Natural is the #1 Skin Care Seller on Amazon Canada for the past 4 years. Mimi’s Rock will acquire all of the issued and outstanding shares of each of All Natural and Maritime Naturals for an aggregate purchase price of $9,636,000. The acquisition of these accretive businesses will fold in the #1 seller of skincare products on Amazon Canada, adding approximately $5.5 million of revenue and $1.6 million of EBITDA. Combined, these two companies delivered a 54% compound annual growth rate over the last five years, with no debt.

‘We are very excited to add the All Natural and Maritime Naturals brands to our portfolio. These companies have a history of strong financial performance and will immediately open additional markets for us. The brand exposure and potential for cross-selling to existing customers will be a great benefit,’ says Mimi’s Rock CEO, David Kohler. ‘Access to the premium organic and all-natural beauty segment is a great fit for our company and aligns with our wellness-seeking clientele.’

The purchase price will be satisfied by (i) the payment, in aggregate, of approximately $5.5 million in cash, (ii) the issuance of common shares in the capital of Mimi’s Rock valued at approximately $2.1 million, and (iii) the assumption of a $2 million vendor loan to be repaid within 12 months of closing. The cash portion of the purchase price is expected to be paid from a combination of cash on hand and additional borrowings under a modification of the Company’s long term debt facilities. Further details will be provided in a subsequent news release once determined. Subject to the satisfaction of customary closing conditions, including the execution of definitive agreements and receipt of approval from the TSX Venture Exchange, the acquisitions are expected to close on or about October 15, 2019.

Dave Kohler, CEO of Mimi’s Rock commented, “We are pleased that during the quarter, we executed three important strategic initiatives as planned. We added a new product family and opened a new online channel, in addition to launching our own e-Commerce site. Together, these accomplishments position us well to execute our scaling and expansionary plans.”

Combined Acquisition Highlights:

  • #1 seller of skincare products on Amazon Canada
  • ~$5.5M revenue
  • ~$1.6M EBITDA
  • 54% CAGR over 5 years
  • 45 SKUs
  • Operational in multiple jurisdictions

All Natural and Maritime Naturals currently offer products in Germany, Italy, UK and Australia, giving Mimi’s Rock immediate access to these markets. Their products will allow Mimi’s Rock to offer 45 additional SKUs to its already impressive basket of products by offering anti-aging organic skincare products, all-natural masks & scrubs, acne blemish treatments, beard oils and more..

About All Natural Advice & Maritime Naturals.

All Natural Advice and Maritime Naturals, based in Ontario and Nova Scotia, respectively, are companies focused on skin and beauty care. Products sold by All Natural and Maritime Naturals are made in Canada and registered with Health Canada and under the EU Cosmetics Act. Together, All Natural and Maritime Naturals have over 45 products in jurisdictions around the world. All Natural has been featured on BNN as a top selling skincare brand in Canada and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

About Mimi’s Rock Corp.

Mimi’s Rock Corp. is an online dietary supplement and wellness company. The leading brand of Mimi’s Rock is Dr. Tobias, which features more than 30 products, including the top-selling Colon Cleanse and the #1 selling Omega 3 Fish Oil, which is also the fourth largest Subscribe and Save product on Amazon.com. Mimi’s Rock currently serves customers in the United States through Amazon.com, Walmart.com, Jet.com and Dr. Tobias.com, with a plan to expand into other markets. For more information, visit Mimisrock.com.

Forward-Looking Informationv

Certain forward-looking statements contained in this news release that are based on the current expectations of management involve risks and uncertainties This ‘forward-looking information’, as the term is defined in applicable securities laws, includes, without limitation, the business and business results, goals, or outlook of Mimi’s Rock; risks associated with financial results and stability; development projects such as those referenced herein; sales to foreign jurisdictions; engineering and construction; production (including control over costs, quality, quantity, and timeliness of delivery); foreign currency and exchange rates; maintaining adequate working capital and raising further capital on acceptable terms or at all; and other similar statements concerning anticipated future events, conditions, or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions, and expectations; they are not guarantees of future performance. The Company cautions that all forward-looking information is inherently uncertain and a number of material factors, many of which are beyond the Company’s control, may affect actual performance. Accordingly, actual future events, conditions, and results may differ materially from the estimates, beliefs, intentions, and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this news release. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking, including those identified by the expressions ‘aim’, ‘anticipate’, ‘appear’, ‘believe’, ‘consider’, ‘could’, ‘estimate’, ‘expect’, ‘if’, ‘intend’, ‘goal’, ‘hope’, ‘likely’, ‘may’, ‘plan’, ‘possibly’, ‘potentially’, ‘pursue’, ‘seem’, ‘should’, ‘whether’, ‘will’, ‘would’, and similar expressions. Forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Except as required by law, Mimi’s Rock does not assume any obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Article Source: Web.Tmxmoney.com

View original content: Newswire.ca/News-Release

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO
905-350-5081
DKohler@mimisrock.com

Jackie Kelly, Investor Relation
416-301-2949
info@mimisrock.com 

TORONTO, August 29, 2019.

Source: Canada NewsWire

TORONTO, August 29, 2019 – Mimi’s Rock Corp. (TSXV:MIMI) “The Company”, an online dietary supplement and wellness company operating the Dr. Tobias brand, today announced its financial results for the quarter ended June 30, 2019.

For the three months ended June 30, 2019, the Company incurred a net loss of $1,240,051 compared to a net loss of $nil for the three months ended June 30, 2018. For the three months ended June 30, 2019, EBITDA was $460,008, compared to EBITDA of $nil for the three months ended June 30, 2018. Adjusted EBITDA, which excludes non-cash share based compensation expense, investment income and acquisition costs, was $1,382,117, compared to Adjusted EBITDA of $nil for the same period in the prior year. For the six months ended June 30, 2019, the Company incurred a net loss of $848,134 ($0.04 per share), compared to a net loss of $nil ($0.00 per share) for the six month period ended June 30, 2018. EBITDA for the six months ended June 30, 2019 was $1,557,921, compared to $nil EBITDA for the same period in the prior year. Adjusted EBITDA was $2,700,637 for the six months ended June 30, 2019, compared to $nil for the same period in 2018.

The Company reported a net loss for the three and six months ended June 30, 2019 primarily due to one-time costs related to its reverse takeover and public listing expenses as part of the Qualifying Transaction completed in May 2019, as well as non-cash share-based compensation expense. Tax expense in the period was also higher due to derecognition of tax loss carryforwards in Germany as a result of the reverse acquisition. During the second quarter, the Company began to generate sales from its own e-commerce site, drtobias.com, as well through additional online retail outlets. The Company also launched a private label brand in conjunction with its e-commerce channel partner.

Dave Kohler, CEO of Mimi’s Rock commented, “We are pleased that during the quarter, we executed three important strategic initiatives as planned. We added a new product family and opened a new online channel, in addition to launching our own e-Commerce site. Together, these accomplishments position us well to execute our scaling and expansionary plans.”

Revenues for the three months ended June 30, 2019 were $8,770,904, compared to $nil for the three months ended June 30, 2018, due to the acquisition of the DTI business in July 2018. Revenues represent sales of nutraceutical products in the U.S. market. Gross margin for the three months ended June 30, 2019 was $6,208,319 (70%) compared to $nil for the three month period ended June 30, 2018. Gross margin ratios have improved slightly on a quarter over quarter basis as the Company works with its supplier to obtain better pricing and efficiencies.

While the Company’s sales do not experience significant seasonality, there is some fluctuation on a quarterly basis due to natural demand fluctuation as well as promotional impacts. The Company continues to redevelop its brand strategy. As online advertising in the period was scaled back to evaluate returns on investment, sales volumes were somewhat lower while margins remained consistent.

The Company incurred selling and marketing expenses of $3,523,242, or approximately 40% of revenue, for the three months ended June 30, 2019, compared to $nil for the three months ended June 30, 2018. Sales and marketing expenses for the period consist primarily of fulfillment costs related to delivering products to customers, direct online advertising placements, costs related to marketing the Dr. Tobias brand and other promotional and awareness initiatives. The Company will continue to actively monitor its selling and marketing expenses, particularly those directly related to advertising and expects that these will increase in relation to sales revenues going forward.

General and administrative expenses for the three months ended June 30, 2019 were $1,302,960, compared to $nil for the same period in 2018. General and administrative expenses consist primarily of salaries and benefits, professional fees, occupancy costs and insurance. General and administrative expenses in the current period have normalized somewhat now that one-time costs associated with operational start-up and time and efforts spent engaged in understanding and integrating the DTI business have diminished. Share based compensation expense for the three months ended June 30, 2019 was $194,800 compared to $nil for the three months ended June 30, 2018. Share based compensation expense relates to awards under the Company’s incentive stock option plan and is based on the estimated number of awards that will eventually vest using the Black-Scholes option pricing model.

On May 27, 2019, the Company completed its Qualifying Transaction pursuant to an amalgamation agreement between the Company and Mimi’s Rock Inc. The Qualifying Transaction constituted a reverse take-over (“RTO”) for accounting purposes, as former MRI shareholders hold a majority of outstanding shares in the Company, the Board of Directors is comprised of MRI Board members and the senior management of MRI became senior management of the Company. Although the Company will be regarded as the legal parent, MRI is considered to be the acquirer for accounting purposes. Consequently, the Company is deemed to be a continuation of MRI. As a part of the Qualifying Transaction, the Company changed its name from “Commerce Acquisition Corp.” to “Mimi’s Rock Corp.”.

Listing expenses related to the acquisition and reverse takeover transaction for the three months ended June 30, 2019 were $697,787, compared to $nil for the same period in the prior year. Listing expenses consist primarily of legal, accounting and other professional fees associated with the reverse takeover and amalgamation, as well as non-cash costs related to equity instruments issued for the acquisition.

Interest and financing costs of $533,475 were incurred during the three months ended June 30, 2019, compared to $nil for the three months ended June 30, 2018. Interest and financing expenses in the current quarter include approximately $189,644 in non-cash charges related to amortization of expenses incurred in securing the Company’s senior secured loan, as well as $88,212 related to dividends in kind paid on the Preferred B shares prior to conversion in connection with the reverse takeover transaction.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. is an online dietary supplement and wellness company operating under the Dr. Tobias brand. The brand features over 30 products including the top selling colon cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. Mimi’s Rock currently serves customers in the United States and has rapid growth plans to expand into other markets. For more information, visit Mimisrock.com.

Forward-Looking Information

This news release includes “forward-looking information,” as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO
905-350-5081
DKohler@mimisrock.com

Jackie Kelly, Investor Relation
416-301-2949
info@mimisrock.com 

TORONTO, July 8, 2019

Source: Canada NewsWire

TORONTO , July 8, 2019 /CNW/ – Mimi’s Rock Corp. (MIMI.V) (‘The Company’), an online dietary supplement and wellness company operating the Dr. Tobias brand, is pleased to announce that it has entered into a Joint Venture Agreement with three-time world heavyweight champion Lennox Lewis to develop and commercialize a new line of branded nutritional supplements.

Lennox Lewis, nicknamed ‘The Lion’, is a retired professional boxer who remains the last heavyweight to hold the undisputed title. He competed from 1989 to 2003, and is a three-time world heavyweight champion and two-time Lineal champion. Holding dual British and Canadian citizenship, Lewis represented Canada as an amateur in the 1988 Summer Olympics, winning a gold medal in the super-heavyweight division.

The global fan base Lennox has attracted throughout the years, and the rapid growth of online sales and advertising create a massive opportunity to target customers with an interest in sports nutrition. On Facebook alone, there is an is an estimated audience of over 150 million active users who show an interest in boxing, with 71% being men and the remaining 29% women. The global dietary supplements market is growing at 10% CAGR for the period 2016-2024, according to Statista.com.

David Kohler, CEO ‘We are excited to partner with Lennox on this new family of products, which will focus on Health and Wellness for men. During his time in the ring and since, Lennox has remained much loved by his fans, likely because of the way he carried himself both inside and outside of the ring. He is an upbeat and inspiring athlete who has always taken tremendous care of his body. He is aligned with our values and focus on Wellness. We see significant synergies and the opportunity to positively impact lives with his influence.’

Mimi’s Rock will provide sourcing, distribution, channels, sales and marketing, and will obtain all regulatory approvals, in respect of the products. Lennox will grant to Mimi’s Rock a license to use his name and likeness, and will provide social media and marketing support in respect of the products. The License will be worldwide and will last for 36 months. The License will be exclusive to Mimi’s Rock in respect of the products and nutritional supplements that are reasonably expected to be competitive with the products. Significant marketing and branding decisions will require the unanimous approval of both parties. The transaction is subject to the execution of a definitive agreement..

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. is an online dietary supplement and wellness company operating under the Dr. Tobias brand. The brand features over 30 products including the top selling Colon Cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. The Omega 3 Fish Oil is also the 4th largest subscribe & save product on Amazon.com. Mimi’s Rock currently serves customers in the United States through Amazon.com, Walmart.com, and Dr. Tobias.com, with a rapid growth plan to expand into other markets. For more information, visit Mimisrock.com.

Forward-Looking Information

This news release includes certain forward-looking statements that are based upon the current expectations of management. Forward-looking statements involve risks and uncertainties This news release includes ‘forward-looking information,’ as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, discussion of Bloom Burton and its conference, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.associated with the businesses of Avivagen Inc., Mimi’s Rock Corp and the joint venture described above and the environment in which those businesses operate. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking, including those identified by the expressions ‘aim’, ‘anticipate’, ‘appear’, ‘believe’, ‘consider’, ‘could’, ‘estimate’, ‘expect’, ‘if’, ‘intend’, ‘goal’, ‘hope’, ‘likely’, ‘may’, ‘plan’, ‘possibly’, ‘potentially’, ‘pursue’, ‘seem’, ‘should’, ‘whether’, ‘will’, ‘would’ and similar expressions. Statements regarding the plan to sell product online through this joint venture, the potential for the joint venture to produce profits and other benefits that will be shared by Avivagen and Mimi’s Rock and the expected timing for product launch are forward looking statements. Forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. For instance, the products to be sold by the joint venture may not gain market acceptance or regulatory approval where required, leading to lower than expected profits and benefits and products may take longer to bring to market than currently anticipated, in each case due to many factors, many of which are outside of the control of the parties. Except as required by law, neither Avivagen nor Mimi’s Rock assumes any obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements.

Article Source: Finance.yahoo.com/news

Original Content: Newswire.ca

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO
905-350-5081
DKohler@mimisrock.com

TORONTO and OTTAWA, June 13, 2019

Source: Canada NewsWire

TORONTO and OTTAWA, June 13, 2019 /CNW/ – Mimi’s Rock Corp. (TSXV:MIMI or ‘Mimi’s Rock’), an online dietary supplement and wellness company operating under the Dr. Tobias brand and with significant sales on the Amazon.com platform, and Avivagen Inc. (TSXV:VIV) (‘Avivagen’ or the ‘Corporation’), owner of the intellectual property protected OxC-beta™ technology that supports the optimal health of companion animals, are pleased to announce a Joint Venture agreement focused on the online sale of nutritional supplements for cats and dogs. Under the terms of the agreement, Avivagen will supply its products that include its proprietary OxC-beta™ technology and Mimi’s Rock will market and sell the product through its state of the art e-commerce platform and online global channels. This joint venture will be the exclusive channel through which Avivagen sells nutritional supplements for cats and dogs online. All sales will be conducted through a newly formed corporation jointly owned by Avivagen and Mimi’s Rock. The profits will be shared equally between the two companies.

Mimi’s Rock is an expert online marketer of brands for the human dietary supplement and wellness market, with a proprietary e-commerce site, significant sales via Amazon.com and other significant online channels and partners coming on-stream. Under the Dr. Tobias brand, owned by Mimi’s Rock, sales have grown at a compound annual rate of over 30%. Dave Kohler, CEO of Mimi’s Rock commented, ‘We have engaged with our customers, who care deeply about health and wellness and quality of products, and believe that the next product opportunity to serve their needs is in the growing companion animal market. We estimate that online sales of products for pets is a US$10.5 billion per year market globally and we believe that Avivagen’s OxC-beta™ technology will offer our customers unique, rigorously tested and scientifically backed products for the best care of their pets.’

Kym Anthony, CEO of Avivagen declared, ‘We believe that the deep scientific backing and testing, along with patents that cover our OxC-beta™ technology are ideally suited to make proprietary, exclusive and powerful products to provide their pet parents and that Mimi’s Rock has cracked the code of customer engagement and service to the next level. We have examined multiple partnering opportunities and we are both excited and delighted to be partnering with Mimi’s Rock, based on their deep knowledge of online marketing, significant traction across many products and a wonderful understanding of their customers’ needs.’

It is expected that a first product will be launched by the Joint Venture in the first quarter of 2020. The two companies will report further on the launch and progress in future public disclosures.

About Mimi’s Rock:

Mimi’s Rock Corp. operates an online dietary supplement and wellness company, with the primary brand being delivered as Dr. Tobias. The brand features over 30 products including the top selling colon cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. Mimi’s Rock currently serves customers in the United States and has plans to expand into other markets. With an estimated value of $133 Billion in 2016, the global dietary supplements market is projected to accelerate at a rate of 9.6%, reaching over $278 Billion by 2024. The online market for pet products is estimated at US$10.5 billion.

About Avivagen:

Avivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance. It is a public corporation traded on the TSX Venture Exchange under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada and Charlottetown, Prince Edward Island. For more information, visit Avivagen.com. The contents of the website are expressly not incorporated by reference in this press release.

About OxC-beta™ Technology:

Avivagen’s OxC-beta™ technology is derived from Avivagen discoveries about carotenoids, compounds that give certain fruits and vegetables their bright colours, and is a non-antibiotic means of maintaining optimal health and growth.

Forward Looking Statements:

This news release includes certain forward-looking statements that are based upon the current expectations of management. Forward-looking statements involve risks and uncertainties associated with the businesses of Avivagen Inc., Mimi’s Rock Corp and the joint venture described above and the environment in which those businesses operate. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking, including those identified by the expressions ‘aim’, ‘anticipate’, ‘appear’, ‘believe’, ‘consider’, ‘could’, ‘estimate’, ‘expect’, ‘if’, ‘intend’, ‘goal’, ‘hope’, ‘likely’, ‘may’, ‘plan’, ‘possibly’, ‘potentially’, ‘pursue’, ‘seem’, ‘should’, ‘whether’, ‘will’, ‘would’ and similar expressions. Statements regarding the plan to sell product online through this joint venture, the potential for the joint venture to produce profits and other benefits that will be shared by Avivagen and Mimi’s Rock and the expected timing for product launch are forward looking statements. Forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. For instance, the products to be sold by the joint venture may not gain market acceptance or regulatory approval where required, leading to lower than expected profits and benefits and products may take longer to bring to market than currently anticipated, in each case due to many factors, many of which are outside of the control of the parties. Except as required by law, neither Avivagen nor Mimi’s Rock assumes any obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Article Source: Web.tmxmoney.com

Original Content: Newswire.ca

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO
905-350-5081
DKohler@mimisrock.com

TORONTO, June 6, 2019

Source: Canada NewsWire

TORONTO, June 6, 2019 /CNW/ – Mimi’s Rock Corp. (TSXV:MIMI) ‘The Company’, an online dietary supplement and wellness company operating under the Dr. Tobias brand, is pleased to announce that it has launched its new e-commerce platform, developed by Commerce Dynamics.

‘We are thrilled to provide Mimi’s Rock a state of the art e-commerce platform to engage their users who have made Dr. Tobias a U.S. leader in the online sale of supplements and vitamins,’ says Kevin Smith, Senior Partner at Commerce Dynamics. ‘We have worked very hard over the last few months with the team at Mimi’s Rock to provide their customers, not only a great shopping experience, but a safe and scalable solution for all Dr. Tobias products.’

David Kohler, CEO of Mimi’s Rock Corp, states ‘I’m extremely pleased and excited to see the launch of our new site. It is important that we always focus on being available for our customers through whichever channel works best for them. Adding this important vehicle is an important step in furthering our customer engagement.’

The new e-commerce website will feature the full suite of Dr. Tobias products, and will ship within the United States. Offering an in-house platform will allow Mimi’s Rock to continue to monitor and improve their customer experience, analyze data patterns, and expand customer reach. The site will be both PC and mobile friendly.

About Commerce Dynamics:

Commerce Dynamics partners with world-class brands to further online success and transform customer engagement. Their solutions power brands with the technology to grow differently. For more information, visit https://www.commercedynamics.com/solutions.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. is an online dietary supplement and wellness company operating under the Dr. Tobias brand. The brand features over 30 products including the top selling colon cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. Mimi’s Rock currently serves customers in the United States, and has rapid growth plans to expand into other markets. For more information, visit Mimisrock.com.

Forward Looking Information

This news release includes ‘forward-looking information,’ as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, discussion of Bloom Burton and its conference, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Article Source: Web.tmxmoney.com

Original Content: Newswire.ca

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO
905-350-5081
DKohler@mimisrock.com

PRESENTATION

Corporate Overview

Mimi's Rock is a diverse, global group of health and business professionals dedicated to offering a wide selection of wellness products that we are proud to stand behind. Mimi's Rock was founded to build a significant growth platform in the consumer healthcare space. The acquisition of Dr. Tobias provides Mimi's Rock with an initial, large consumer health product portfolio with over 30 branded products in the vitamin, health supplements, and wellness categories. We are committed to exceed our customers' expectations, while aiding them in improving their overall wellness. We want to make it a way for them to achieve what they believe to be possible.

filingInfoImage.png

Financials & Filings

CORP Q4

MD & A

Interm Financial Statement

CORP Q3

Interim Financial Statement

CORP Q2

MD & A

Interim Financial Statement

CORP Q1

MD & A

Interm Financial Statement

Inc Q1

Financial Statment of RTO Acquirer

Filing Statement

Filing Statement

AGM

Form of Proxy

Management Information Circulation

Notice of Meeting

Annual Source Report: Sedar

MARKET:

SYMBOL:

MARKET:

SYMBOL:

COPORATE GOVERNANCE

Board of Directors

TELFER
HANSON

Executive Chairman

The year was 1967 and 4-year-old me walking through the Toronto Maple Leafs dressing room, with a program in each hand, signed by every player on the Stanley Cup winning team. I knew I had just won the lottery. Born and raised in Moore Park Toronto, I lived in the city for the first 25 years of my life. You can catch me any day of the week watching endless hours of CNN – I am a news junkie (so my wife says). With 30 years in the investment banking world, the majority were spent in the medical device industry. I have a love for travel. During the winter months you will very easily find my wife and I lying on a beach, Kobos in hand, enjoying the sun. Reach out whenever you want to chat about sports, travel, or anything around the world as I consider myself a beacon of knowledge – or as I say – I know a whole lot about a whole little.

DAVID
KOHLER

Chief Executive Officer & DIRECTOR

I may be the luckiest guy I know. Great Family – check. Great Team at work – check. Great friend network – check.

Now, following a long run with a leading pharmaceutical company, I’ve moved into the dietary supplement business. I have the privilege of leading a group of passionate individuals looking to make a difference in the Health and Wellness space. I’m impressed daily by their creativity and energy. And when I’m not having fun at work, you can find me chasing one of my many, disparate interests. I also love to be active. Golf, hiking, cycling, running, the gym or just hanging out outdoors. So give me a call if you want to discuss any of these areas, but WARNING: if you’re a Dallas Cowboys or Montreal Canadiens fan, I may not pick up your call!

DAVID
GRANDIN

BOARD MEMBER

Mr. Grandin has over 20 years of experience starting companies and building teams in the high-tech sector. He combines a strong entrepreneurial skill set with an extensive background in software and integrated system development, digital media solutions and sports-related technology. Mr. Grandin has a Bachelor’s of Science in Electrical Engineering and Computer Science from the University of Wisconsin and an MBA in High Technology from Northeastern University.

NORMAN
BETTS

BOARD MEMBER

Mr. Betts has extensive experience in financing, accounting and audit in the public sector, having served on the board of several public companies. Mr. Betts served as the Minister of Finance in New Brunswick from 1999 to 2001 and as and Minister of Business in New Brunswick from 2001 to 2003. He currently sits on the boards of New Brunswick Power Corp. and Bank of Canada. Mr. Betts has a Bachelor’s of Business Administration degree from the University of New Brunswick and a PhD in Accounting and Finance from Queen’s University.

BRYAN
PEARSON

BOARD MEMBER

Mr. Pearson has three decades of experience within the loyalty and marketing sector. An internationally recognized expert, author, and speaker on customer loyalty and marketing, Mr. Pearson is the current President and CEO of LoyaltyOne, a subsidiary of Alliance Data (NYSE: ADS). A pioneer in loyalty strategies and measured marketing, Pearson and the LoyaltyOne team leverage consumer insights to influence over $160 billion in annual retail sales by working with their clients to create relevant communications and enhanced shopper experiences.

Charmaine
Crooks

Board memeber

Charmaine Crooks is a five time Olympian, entrepreneur and community leader. Based in West Vancouver, Charmaine has over 20 years governance experience as a director on several national and international non-profit and public boards. As president and founder of NGU Consultants Inc (1997), Charmaine has provided strategic advisory and corporate development services to a variety of sectors including health, technology, sports and major events. 

Recognized in 2018 as one of Canada’s Most Powerful Top 100 by the Women’s Executive Network (WXN), Charmaine is a respected contributor to the international business community.

CONTACT

Info@mimisrock.com

© 2020 Mimi’s Rock, Corp.